Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis

Journal of Autoimmunity

Volumn 30, Issue 4, 2008, Pages 238-245

  Allina, Jorge ^a   Stanca, Carmen M ^a   Garber, John ^a   Hu, Bin ^a   Sautes Fridman, Catherine ^b   Bach, Nancy ^a   Odin, Joseph A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b INSTITUT CURIE   (France)

Author keywords

Autoimmunity; Complement receptor 3; Fc receptor; Macrophage; Opsonization

Indexed keywords

AUTOANTIBODY; CD16 ANTIGEN; CD16 AUTOANTIBODY; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 3; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; APOPTOSIS; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MALE; MONOCYTE; OPSONIZATION; PHAGOCYTOSIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SERUM FACTOR; STATISTICAL SIGNIFICANCE;

APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MACROPHAGES; MALE; MIDDLE AGED; OPSONIN PROTEINS; PHAGOCYTOSIS; RECEPTORS, IGG;

EID: 42249116039     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.10.003     Document Type: Article

References (37)

1. Peng Y., Martin D.A., Kenkel J., Zhang K., Ogden C.A., and Elkon K.B. Innate and adaptive immune response to apoptotic cells. J Autoimmun (2007; Sep 19) [Epub ahead of print]
2. Gaipl U.S., Munoz L.E., Grossmayer G., Lauber K., Franz S., Sarter K., et al. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun 28 (2007) 114-121
3. O'Brien B.A., Geng X., Orteu C.H., Huang Y., Ghoreishi M., Zhang Y., et al. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun 26 (2006) 104-115
4. Ghebrehiwet B., and Peerschke E.I. Role of C1q and C1q receptors in the pathogenesis of systemic lupus erythematosus. Curr Dir Autoimmun 7 (2004) 87-97
5. Herrmann M., Voll R.E., Zoller O.M., Hagenhofer M., Ponner B.B., and Kalden J.R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41 (1998) 1241-1250
6. Roos A., Xu W., Castellano G., Nauta A.J., Garred P., Daha M.R., et al. Mini-review: a pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 34 (2004) 921-929
7. Boros P., Odin J.A., Chen J., and Unkeless J.C. Specificity and class distribution of Fc gamma R-specific autoantibodies in patients with autoimmune disease. J Immunol 152 (1994) 302-306
8. Lamour A., Baron D., Soubrane C., Cartron J., Khayat D., Adler Y., et al. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid. J Autoimmun 8 (1995) 249-265
9. Morgan A.W., Griffiths B., Ponchel F., Montague B.M., Ali M., Gardner P.P., et al. Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Arthritis Rheum 43 (2000) 2328-2334
10. Preynat-Seauve O., Villiers C.L., Jourdan G., Richard M.J., Plumas J., Favier A., et al. An interaction between CD16 and CR3 enhances iC3b binding to CR3 but is lost during differentiation of monocytes into dendritic cells. Eur J Immunol 34 (2004) 147-155
11. Kaplan M.M., and Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 353 (2005) 1261-1273
12. Allina J., Hu B., Sullivan D.M., Fiel M.I., Thung S.N., Bronk S.F., et al. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27 (2006) 232-241
13. Aoki C.A., Roifman C.M., Lian Z.X., Bowlus C.L., Norman G.L., Shoenfeld Y., et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 27 (2006) 50-53
14. Salunga T.L., Cui Z.G., Shimoda S., Zheng H.C., Nomoto K., Kondo T., et al. Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun 29 (2007) 78-86
15. Jaffe C.J., Vierling J.M., Jones E.A., Lawley T.J., and Frank M.M. Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest 62 (1978) 1069-1077
16. Nilsson Ekdahl K., Loof L., Ahrenstedt O., Nilsson U.R., and Nilsson B. Defective elimination of C3b/iC3b-coated autologous erythrocytes in patients with primary biliary cirrhosis, alcoholic cirrhosis, and ulcerative colitis. J Lab Clin Med 130 (1997) 285-292
17. Minuk G.Y., Vergalla J., Hanson R.G., Hoofnagle J.H., Frank M.M., and Jones E.A. Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis. Gut 27 (1986) 324-328
18. Odin J.A., Huebert R.C., Casciola-Rosen L., LaRusso N.F., and Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 108 (2001) 223-232
19. Tsuneyama K., Van De Water J., Yamazaki K., Suzuki K., Sato S., Takeda Y., et al. Primary biliary cirrhosis an epithelitis: evidence of abnormal salivary gland immunohistochemistry. Autoimmunity 26 (1997) 23-31
20. Al-Aghbar M.N., Neuberger J., Williams R., and Eddleston A.L. Mononuclear cell complement receptor blockade in primary biliary cirrhosis. Gut 26 (1985) 20-25
21. Wyke R.J., Rajkovic I.A., and Williams R. Impaired opsonization by serum from patients with chronic liver disease. Clin Exp Immunol 51 (1983) 91-98
22. Spittler A., Willheim M., Leutmezer F., Ohler R., Krugluger W., Reissner C., et al. Effects of 1 alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis. Immunology 90 (1997) 286-293
23. Loof L., Hakansson L., Nyberg A., and Venge P. Defective C3b receptor-mediated phagocytosis of neutrophils in patients with primary biliary cirrhosis. Scand J Gastroenterol 22 (1987) 1169-1174
24. Lleo A., Invernizzi P., Selmi C., Coppel R.L., Alpini G., Podda M., et al. Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 29 (2007) 61-68
25. Pittoni V., and Valesini G. The clearance of apoptotic cells: implications for autoimmunity. Autoimmun Rev 1 (2002) 154-161
26. Fossati G., Bucknall R.C., and Edwards S.W. Fcgamma receptors in autoimmune diseases. Eur J Clin Invest 31 (2001) 821-831
27. Hatjiharissi E., Xu L., Santos D.D., Hunter Z.R., Ciccarelli B.T., Verselis S., et al. Increased natural killer cell expression of CD16, and augmented binding and ADCC activity to rituximab among individuals expressing the Fc{gamma}RIIIA-158 V/V and V/F polymorphism. Blood 110 7 (2007) 2561-2564
28. Kumpel B.M., De Haas M., Koene H.R., Van De Winkel J.G., and Goodrick M.J. Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of Fcgamma RIIIa (CD16). Clin Exp Immunol 132 (2003) 81-86
29. Gavasso S., Nygard O., Pedersen E.R., Aarseth J.H., Bleie O., Myhr K.M., et al. Fcgamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis 180 (2005) 277-282
30. Ohkuro M., Ogura-Masaki M., Kobayashi K., Sakai M., Takahashi K., and Nagasawa S. Effect of iC3b binding to immune complexes upon the phagocytic response of human neutrophils: synergistic functions between Fc gamma R and CR3. FEBS Lett 373 (1995) 189-192
31. Fan L.Y., Zhong R.Q., Tu X.Q., Zhu Y., Gong C.L., Zhou L., et al. [Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune liver diseases on Chinese]. Zhonghua Yi Xue Za Zhi 83 (2003) 1852-1855
32. Vogel A., Strassburg C.P., and Manns M.P. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 35 (2002) 126-131
33. Selvaraj P., Chandra G., Jawahar M.S., Rani M.V., Rajeshwari D.N., and Narayanan P.R. Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. J Clin Immunol 24 (2004) 523-532
34. Corpechot C., Benlian P., Barbu V., Chazouilleres O., Poupon R.E., and Poupon R. Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?. J Hepatol 35 (2001) 324-328
35. Grainger D.J., Reckless J., and McKilligin E. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol 173 (2004) 6366-6375
36. Kikuchi K., Lian Z.X., Kimura Y., Selmi C., Yang G.X., Gordon S.C., et al. Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J Autoimmun 24 (2005) 347-352
37. Matsushita M., Miyakawa H., Tanaka A., Hijikata M., Kikuchi K., Fujikawa H., et al. Single nucleotide polymorphisms of the mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis. J Autoimmun 17 (2001) 251-257